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    Stroke is the third leading cause of death in the United States, exhibiting disproportional 
prevalence in minority communities. During stroke, restriction of blood supply to brain areas causes 
brain ischemia, generating a neurodegenerative cascade called excitotoxicity. Excitotoxicity is caused 
by the malfunction of glutamate (Glu) transporters (GluTs, a system that normally clears up the 
excess of excitatory neurotransmitter glutamate from the synaptic cleft). The malfunction of GluTs 
leads to a buildup of Glu in the synapse, thus overstimulating the Glu receptors (GluRs) located on 
the post-synaptic neuron.  As a result, an overwhelming influx of Na+ and Ca2+ causes toxicity in the 
post-synaptic neuron leading to necrotic cell death. Current treatments developed to ameliorate brain 
ischemia have very limited success and the molecular and cellular mechanisms that regulate the 
process of excitotoxicity remain largely unclear. Recent reports suggest that the process of 
excitotoxic cell death might be regulated by two related factors: Death-Associated Protein Kinase 
(DAPk, a critical master molecular cell death switch involved in several cell death pathways) and 
autophagy. However, the relationship between these two factors and the molecular basis for their 
potential role in excitotoxicity remain unknown. To understand the involvement of DAPk and 
autophagy in excitotoxicity, we simulate excitotoxic-like conditions in the nematode C. elegans, an 
effective and genetically accessible animal system. Glu-triggered neuronal necrosis in the nematode 
is generated in our lab by knocking out the GluT gene glt-3 in combination with a sensitizing genetic 
background to cause an excitotoxic-like neurodegeneration. In my studies I have shown that absence 
of the nematode homolog of DAPk strongly reduces the levels of necrotic neurodegeneration while its 
overexpression exacerbates cell death. In contrast to the strong effect of DAPK, absence of 
autophagy only moderately affects neurodegeneration. These observations suggest that the lion’s 
share of DAPk’s effect on excitotoxicity is exerted by means other than autophagy. Of the many 
candidate pathways known to be regulated by DAPk I have selected a number of more promising 
ones (as they are known to regulate neuronal function) for further analysis. I am currently continuing 
our pursuit to elucidate the molecular mechanisms that lead to nematode excitotoxicity by looking at 
the possible DAPk-mediated signaling cascades and test their involvement in the process of cell 
death. Gaining insights into the molecular mechanisms by which DAPk is involved in nematode 
excitotoxicity might provide new clues to help us understand similar processes in mammalian brain 







Stroke is a major health concern in the United States. It is the third leading cause of long-term 
disability and hospitalization with a disproportional prevalence in minority communities1,2.  In the 
United States, About 800,000 people suffer a stroke and ~18% of those people die from it every 
year3. During stroke, neurons are susceptible to massive neurodegeneration leading to tissue 
damage of different brain areas. Stroke-related brain damage is a progressively worsening process 
that causes gradual deterioration from the time of first symptoms, through patient admission to the 
hospital, to hours and even days later after stroke onset, giving us a window of opportunity for 
therapeutic treatments. However, the effectiveness of current treatments is very limited, and 
pharmacological trials to combat the neurodegenerative process were a great disappointment 4,5 . 
Typically, brain ischemia is initiated by a clot that obstructs the passage of blood to cerebral arteries, 
depriving brain areas of energy and causing extensive tissue damage. Neurons located at the core of 
stroke are acutely deprived of oxygen and glucose and suffer a harsh insult, causing them to die 
quickly by necrosis. In contrast, neurons located at penumbra (area located at the periphery of the 
damaged brain area) are stunned and vulnerable to die hours or days after stroke onset 6, 7. 
Therefore, neurons located at these areas could potentially be protected from severe neuronal 
damage if adequate treatment is provided 8. Elucidating the molecular and cellular mechanism during 
ischemia is still challenge, but understanding the events that triggers brain ischemia could help us to 






Mechanism of Neurodegeneration by Excitotoxicity 
       During ischemia, one of the processes that seem to be more sensitive to the decrease in energy 
supply by glucose and oxygen depletion is the removal of the excitatory neurotransmitter Glu by 
GluTs. GluTs are secondary active transporters responsible for clearing the excess amount of Glu 
from synapses. Glu is mobilized across the membrane by co-transporting 3 Na+ ions with one 
molecule of Glu and counter-transporting one K+ ion9,10,11,12. GluTs depend on the Na+/K+/ATPase 
pumps to provide Na+ and K+ gradients to bring Glu from the synapse into surrounding cells. Changes 
in Na+/ K+ gradients can lead to malfunction of GluTs and increase the concentration of Glu in the 
synapses. The increase in Glu concentration in the synapses causes overstimulation of the three 
Ionotropic GluRs (ligand gated ion channels): N-methyl-D- aspartate (NMDA-R), α-amino-3-hydroxyl-
5-methyl-4-isoxazole-propionate (AMPA-R) and kainate receptors (KA-Rs). The excessive 
depolarization of the post-synaptic cell by the over- stimulation of the AMPA-Rs  and the unrestrained 
opening of the NMDA-Rs causes a large influx of Ca2+ and triggers a neurodegenerative process 
called excito-toxicity13
,





While neurons located at the core area of the stroke face a highly toxic Ca2+ overload, thus dying by 
necrosis, neurons located at the penumbra receive a smaller Ca2+ overload allowing them to die by 
apoptosis16,17,18 (Fig 2) .  The molecular and cellular mechanisms that govern neuronal cell death in 
excitotoxicity are still unknown. However, a number of research groups have recently reported that 
Death-Associated Protein Kinase (DAPk), a master regulatory molecular cell death switch, might be 










Death-Associated Protein Kinase: a master regulatory switch in cell death and other cell signaling 
events 
Death-Associated Protein Kinase (DAPk) is a calcium/calmodulin (CaM)-regulated Ser/Thr 
protein kinase was initially identified as a tumor suppressor for its ability to promote cell death19,20. 
DAPk’s -killing effect is activated by its dis-inhibition, which is regulated by several mechanisms, 
primarily a rise in intracellular Ca2+. DAPk is activated by the binding of CaM to an inhibitory pseudo-
substrate domain in DAPk, by desphosphorylation of an inhibitory autophosphorylation site within the 
CaM-binding domain (on Ser308) 19,21-23, by ER stress24, and by an intrinsic ROC domain responsible 
for dimerization and a RAS-like GTPase activity21. DAPk serves as a critical molecular cell death 
switch, due to its ability to select mechanisms of cell death such as apoptosis and autophagy; DAPk 
activation mediates the selective distinction between autophagy’s pro –survival and pro-death roles 
20,25,26. In addition to DAPk’s central role in autophagic cell death, DAPk also influences (by direct 





phosphorylation or by protein-protein interaction) the activity of multiple critical signaling 
molecules19,27,28. These DAPk substrates/partners include regulators of autophagic and apoptotic cell 
death pathways (see below), and a number of proteins that can regulate glutamate signaling (Fig 3):  
a) Syntaxin-129  , a SNARE-complex protein regulating synaptic vesicle release30,31. DAPk 
phosphorylates Syntaxin 1 at Ser188 , thus decreasing the binding of Syntaxin 1 to MUNC-18, a critical 
protein for synaptic vesicle docking32; b) CaMKK33 , a CaM-activated Kinase Kinase that regulates the 
activity of cytoplasmic CaMK-I and nuclear CaMK-IV34 (CaMKinases are known to be involved in Glu 
signaling). CaMKK activity is inhibited by DAPk ; c) ERK35,36  , an extracellular-signaling pathway 
regulated MAPK37 engaged in reciprocal inhibition with DAPk (MAPKs are known to regulate 
glutamatergic responses in the postsynaptic cell38-41) ; d) Pin142,43 , a parvulins-type propyl isomerase 
that changes the conformations of key phosphorylated proteins44 and controls synaptic activity45,46 
and neurodegeneration47-50 . The activity of Pin1 is inhibited by DAPK. Therefore, DAPk modulates 
the activation and function of a number of critical signaling cascades involved in cell death/cell 
survival pathways and neuronal activity. 
Recent reports have also linked DAPK with brain ischemia and excitotoxicity51. During 
ischemia, the over-stimulation of post-synaptic Ca2+ -permeable GluRs and Ca2+-sensitive 
phosphatase calcineurin52 leads to the activation of DAPk. In contrast, inhibiting DAPk activation 
confers neuro-protection from excitotoxicity53.  Some studies show that DAPk is a downstream 
effector of excitotoxicity and Ca2+ influx by its interaction with its inhibitor -DANGER/MAB-21(a protein 
that regulates the release of  intracellular Ca2+
 54
through the IP3-receptor in the ER55,56). In contrast, 
other studies suggest that DAPk is an upstream regulator of Ca2+ influx by its interaction with the 
NR2B subunit of the NMDA receptor during excitotoxicity57. Therefore, although it is clear that DAPk 
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is a critical molecule for the modulation of excitotoxic neurodegeneration, its exact role and placement 
in the flowchart of the neurodegenerative cascade is still controversial.  
 
 
To start dissecting the possible role of DAPk in neurodegeneration by excitotoxicity, we 
selected DAPk-interacting partners that have a direct connection to known cell death pathways or can 
influence excitotoxic neurodegeneration by modulating glutamate signaling. One of the best studied 
pathways regulated by DAPk is the process of cellular degeneration during autophagy. DAPk directly 
modulates autophagic cell death by phosphorylating the BH3 domain of Beclin 1 (a key regulator of 
autophagy), thus promoting its dissociation from Bcl-2/XL complex and activating the autophagy 
machinery 58,59 (Fig 425). Since other lines of research independently suggest that autophagy might be 
involved in neurodegeneration, the autophagy pathway has the potential to be a point of investigation 





Autophagy: a Type-II Programmed Cell Death and A Possible Mediator of Excitotoxicity 
 
Autophagy is an evolutionarily conserved “self-digestion” mechanism characterized by the digestion 
of intracellular organelles.  During macroautophagy (the most studied and common type of 
autophagy) proteins and organelles subjected to degradation are engulfed by an inclusion membrane 
body called the autophagosome. The autophagosome is later fused to the lysosome where 
sequestered intracellular materials are degraded by lysosomal enzymes60-66. Autophagy was first 
described as a mechanism of cell survival during starvation to preserve the viability of the cell by 
sacrificing cellular components 67. However, later on, emerging research described autophagy also as 
a mechanism of cell death (depending on the cellular circumstances) 68,69,70.  The autophagy pathway 
is carried out by three critical steps that are predominantly regulated by three specific proteins: 1) 
Induction step, regulated by Atg1/ULK1/UNC-51, initiates the formation of phagophores that triggers 
the establishment of the double membrane to sequester organelles. 2) Vesicle nucleation, regulated 
by Atg6/Beclin1/BEC-1, controls the recruitment of other proteins to start generating the inclusion 
membrane to form the phagophore. 3) Vesicle elongation involves the conjugation of lipid 
phosphatidylethanolamine (PE) with Atg8/LC3/LGG-1, allowing this protein to translocate from the 
cytoplasm to the growing autophagosome membrane. Atg8/LC3/LGG-1 then serves to anchor other 
proteins to the inclusion membrane and form a multiprotein complex (where proteins such as Atg5 





        Autophagy has also been linked neurodegeneration during excitotoxic conditions. Some 
studies have shown that neurodegeneration triggered by brain ischemia can be accompanied by 
autophagy (indicating death with autophagy), while others point out that inhibiting autophagy could 
lead to a decrease in neuronal damage (suggesting death by autophagy)72,71. In Lurcher mice (mice 
that harbor a mutation that keeps certain GluRs constitutively active), an extensive depolarization in 
neurons leads to death of Purkinje cells by a process suggested to depend on autophagic cell 
death73, though this suggestion has since met criticism74,75 . It is therefore still unknown to what 
degree DAPk and autophagic cell death are (together or independently) involved in excitotoxicity. 
Facing many difficulties in trying to elucidate the sequence of molecular and cellular events that 
regulate the process of excitotoxicity in mammals, we instead focus our research on a genetically 
accessible simple animal system that exhibits a particularly strong track record in elucidating the 
correct sequence of cell-death processes and a reduced redundancy of signaling cascades.  
Caenorhabditis elegans: A Powerful Animal System to Understand the Molecular and Cellular Events 
during Excitotoxicity 
 
      We use an invertebrate model system, C. elegans, that shows strong evolutionary 
conservation of a number of critical processes such as apoptosis, autophagy, aging, and RNAi 76-86. 
Most importantly, C. elegans offers a unique model of excitotoxicity (see below) and is the only 
genetically accessible non-vertebrate to encode DAPk19,87,88 (DAPk is not found in other invertebrates 
like Drosophila). Furthermore, unlike many invertebrates, C. elegans offers a unique opportunity to 
study excitotoxicity due to the high conservation of the components and the function of Glu 
synapses89-98.  Indeed, in our lab we have previously developed a model of excitotoxicity in C. 
elegans by knocking out the GluT glt-3 in a genetic background that renders neurons more 
susceptible to insult. This sensitivity is due to the presence of nuIs599, a transgene containing multiple 
copies of Pglr-1::GαS* (expressing the constitutively active GαS* in the post-synaptic interneuron under 
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the promoter of the glr-1 gene) and Pglr-1::gfp (expressing gfp in those post-synaptic neurons)
100. We 
have shown that while animals carrying just a constitutively- active GαS* in post-synaptic 
interneurons show necrosis of an average of ~1.5 head neurons/animal, ∆glt-3; nuIs5 mutants show 
exacerbated neurodegeneration with an average necrosis of ~4.5 head neurons/animal (Fig 6). 
Based on the dependence of exacerbated necrosis on Glu accumulation (mediated by GluT KO) and 
on the presence of Ca2+-permeable GluRs of post-synaptic interneurons we concluded that this 
exacerbated neuronal necrosis represents a bona fide form of excitotoxicity in nematodes. We further 
determined that this form of excitotoxicity probably requires the release of Ca2+ from intracellular 
stores / ER. Therefore, with the possible role of DAPk in cell death processes and its possible role in 
the release of Ca2+ from the ER, DAPk became the major focus on my studies.  
 
My current findings propose that although the mechanism of autophagy does not seem to be 
required for excitotoxic neurodegeneration, the level of neurodegeneration is dramatically linked to 
the activity of DAPk. The mechanism by which DAPk regulates necrotic cell death is still unknown, 







Death-Associated Protein Kinase (DAPk) Modulates Nematode Excitotoxicity 
 
To test the involvement of DAPk in nematode excitotoxicity using a genetic approach, we combined 
our C. elegans model of excitotoxicity, Δglt-3; nuIs5, with a DAPk KO mutation - dapk-1(gk219)101,102. 
We looked at the extent of neurodegeneration in dapk-1(gk219); Δglt-3;nuIs5 mutants and saw that 
dapk-1 (gk219) KO strongly reduces excitotoxic neuronal necrosis at all developmental stages, with 
an impressive ~50% reduction at the critical L3 stage (a stage previously shown to exhibit the highest 
levels of necrotic cell corpses, probably due to the maturation of Glu signaling and toxicity up to this 
developmental stage, and the removal of cell corpses in the following stages) (Fig 7a). In order to 
reaffirm the participation of DAPK  in nematode excitotoxicity, we crossed Δglt-3; nuIs5 mutants with 
the strain CZ9277 (frIs7[Pnlp-29::GFP ; Pcol-12:DsRed] (IV) ; juEx1933[Phsp16::DAPK-1 ; Pttx-3::RFP] )
102. 
This strain maintains DAPK constitutively active by overexpression, using the heat-shock-activated 
Phsp16::DAPK-1. We generated a Δglt-3; nuIs5; juEx1933[Phsp16::DAPK-1 ; Pttx-3::RFP] (dapk-1
wt) strain 
and checked the level of neurodegeneration. We found the excitotoxic neurodegeneration induced by 
Δglt-3; nuIs5 was exacerbated by ~60% in worms overexpressing DAPK-1 protein (Fig 7b), 
suggesting that DAPk indeed regulates the process of excitotoxicity.  
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Figure 7 DAPk regulates neurodegeneration in nematode model of excitotoxicity. a, Average number 
of degenerating head neurons at all development stages (L1-Adult) per animal. Each bar represents 
~90 animals carrying either Δglt-3; nuIs5 or dapk-1 (gk219); Δglt-3; nuIs5 mutations. Necrotic corpses 
were counted using Nomarkis/ DIC microscopy (in living animals without anesthesia). Result shows 
that blocking dapk-1 strongly suppresses excitotoxic neurodegeneration from L1 trough Adult.  ***, 
statistically significant difference using z test to compare our strain of excitotoxicity with our generated 
triple mutant strain, p <0.001. b, Number of degenerating neurons per animal. Each bar represents 
~30 animals at each developmental stage. Ex[Phsp-16::DAPK] animals carry an extrachromosomal 
construct triggering over-expression of DAPk following heat shock102. Control group are animals from 
the same plate (exposed to the same heat shock conditions) that do not have the extrachromosomal 
construct juEx1933[Phsp16::DAPK-1 ; Pttx-3::RFP] (as determined by the expression of red fluorescence 
in the AIY neuron from the ttx-3 promoter) and are therefore only Δglt-3;nuIs5. Results show a higher 
level of necrotic cell death in Δglt-3;nuIs5 animals when DAPk is over-active, confirming the role of 








Autophagy is not Required for Nematode Excitotoxicity 
 
I next asked if DAPk regulation of excitotoxic neurodegeneration is correlated with a role for DAPk’s 
most studied downstream pathway, autophagic cell death 103,104. Independently of DAPk, autophagy 
was suggested to be a cell-death mechanism essential to the progression of other forms of neuronal 
necrosis in worms 105,106. We tested the involvement of autophagy in our model of excitotoxicity by 
two different approaches. First, we combined our excitotoxicity model (double mutants Δglt-3;nuIs5), 
with unc-51(e369) to generate unc-51(e369); Δglt-3;nuIs5.  unc-51 is one of the main regulatory 
genes in the autophagy pathway responsible for triggering the formation of phagophores to form the 
double membrane that sequester cellular organelles. Animals carrying the unc-51(e369) under the 
excitotoxicity background showed a very moderate though significant reduction in neurodegeneration 
in the L4 stage (but not in other stages) compared to control animals (Fig 8). Secondly, to further 
study the involvement of autophagy, we also monitored autophagy using a LGG-1/LC3 fluorescence 
flag. When autophagy takes place, LGG-1/LC3 aggregates in the cell in the form of puncta throughout 
the autophagosome membrane107.  We used a DsRed version of the flag108,109, Ex[Plgg-1:: 
DsRED::LGG-1 ; Pmyo-2 ::GFP], where autophagy is reportedly marked by both puncta formation and 
overall increase in fluorescence intensity. Animals carrying Ex[Plgg-1:: DsRED::LGG-1 ; Pmyo-2 ::GFP] 
were crossed with Δglt-3;nuIs5 mutants to generate  Ex [Plgg-1:: DsRED::LGG-1 ; Pmyo-2 ::GFP]; Δglt-
3;nuIs5  as the experimental group,  and Ex[Plgg-1:: DsRED::LGG-1 ; Pmyo-2 ::GFP]; nuIs5  as the 
control group. If autophagy indeed mediates the 300% increase in neuronal cell death seen upon 
excitotoxic neurodegeneration, we expected an overall large increase in DsRed signal (in the form of 
intracellular puncta and overall fluorescence) in post-synaptic neurons undergoing excitotoxic 
necrosis. However, we observed only a slight, not statistically significant increase in DsRed intensity 
and in the number of neurons exhibiting puncta in glr-1 expressing neurons when compared to the 
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control group (Fig 9a-c). These results suggest that autophagy is not required for nematode 
excitotoxicity, though low levels of autophagy may accompany excitotoxic neurodegeneration. 
Therefore, although DAPk is a major mediator of nematode excitotoxicity, autophagy, DAPk’s most 













Figure 8, unc-51 is not required for nematode excitotoxicity. More than 100 mutant animals (Δglt-3;GaS* and 
unc-51; Δglt-3;GaS*) at each developmental stage (L1- Adult) were evaluated on the extent  of swollen 
degenerating neurons (“vacuolated” cells when using Nomarski/DIC microscopy). Results show that 
excitotoxic neurodegeneration is moderately reduced when autophagy is blocked by unc-51 mutation only at 
the L4 stage. ***, statistically significant difference using z test to compare our strain of excitotoxicity with our 
generated triple mutant strain, p <0.001. N>100 













Figure 9, Autophagy is not a major feature of nematode excitotoxicity. a, LGG-1::DsRED expression on 
worms carrying either nuIs5 (basal neurodegeneration) or Δglt-3; nuIs5 (nematode excitotoxicity). DsRed 
expression was evaluated in Pglr-1::gfp expressing neurons. b-c, ~25 L3-L4 worms from each generated 
strains (nuIs5 vs Δglt-3; nuIs5) were examined for the presence of autophagy by either determining the 
average DsRed intensity in post-synaptic neurons (b) or the average number of neurons showing puncta 
(c).  No significant differences were found in the average DsRed intensity of control vs experimental 





DAPk does not modulate excitotoxicity by affecting synaptic vesicle release at the 
presynaptic cell and does not affect GluRs on the post-synaptic membrane. 
 
   Our current data shows that autophagy is not crucial for nematode excitotoxicity, suggesting that 
DAPk involvement in excitotoxic neurodegeneration is independent of autophagic cell death. 
However,   DAPk is known to phosphorylate a considerable number of key signaling molecules, and a 
number of those are known to mediate neuronal signaling19. One of the proteins phosphorylated by 
DAPk is Syntaxin-129 , a SNARE-complex protein regulating synaptic vesicle release (although the 
functional consequences of Syntaxin-1 phosphorylation by DAPk remains unclear)30,31.  Since DAPk-
mediated regulation of synaptic vesicle release could control Glu accumulation in the synapse and 
increase post- synaptic activation of GluRs, DAPk KO could reduce the levels of excitotoxic 
neurodegeneration via its possible action on Syntaxin-1 in the pre-synaptic cell.   In order to test this 
hypothesis, we used a behavioral / pharmacological approach, taking advantage of the observation 
that both DAPK-1 and Syntaxin-1 are broadly expressed in many neurons102,110,111. Therefore, a 
putative DAPk-Syntaxin interaction in the worm will affect synaptic vesicle release in all neurons, 
including cholinergic motor neurons. We therefore used WT and dapk-1(gk219) animals, and 
incubated them in the presence of aldicarb, a reversible acetylcholinerase inhibitor. Aldicarb causes 
worm paralysis over time by affecting the mechanism of acetylcholine breakdown, thus over-
activating the acetylcholine receptors (AChRs) at the neuromuscular junction. Comparing Aldicarb 
sensitivity is a standard method of monitoring overall levels of synaptic release, because the more 
ACh is released the quicker the worms become paralyzed in the presence of aldicarb112. However, 
my results showed no significant differences between aldicarb sensitivity of dapk-1(gk219) mutants 
and N2 animals. Both mutants scored a similar time-course of aldicarb induced paralysis (Fig 10). 
Therefore, my data does not support the possibility of a DAPk phosphorylation-mediated effect on 
Syntaxin-1 and synaptic release in the worm.  
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As mentioned above, DAPk was found to regulate the Ca2+ entry through GluRs by interacting 
with the NR2B subunit of the NMDA receptors57. We reasoned that if by acting on GluRs DAPk is also 
an upstream regulator of excitotoxicity, DAPk is likely to be a regulator of normal GluR activity: DAPk 
might change the expression level, trafficking, or activity of GluRs at the membrane, thus increasing 
excitotoxicity in our model.  We tested this hypothesis using a behavioral mobility assay, where we 
measured the time length of forward runs in spontaneous mobility (a movement regulated by 
glutamate signaling in AVA, AVD and AVE interneurons113). To perform this assay, we took L4 –
young adult worms carrying the following mutations: dapk-1(gk219), nmr-1(ak4);glr-2(ak10),glr-
1(ky176) (animals known to be defective in backing response to tactile stimulation89) and  N2  wild 
type animals. Our results show no difference in the length of spontaneous forward runs between 
dapk-1(gk219) mutants and N2 animals (Fig. 11). Therefore, my data do not support an effect of 







Figure 10-11, DAPk does not change synaptic vesicle releases or overall activity of Glutamate 
Receptors. 10) ~30 L4- young adult worms from each corresponding strain were examined for 
possible changes in sensitivity to aldicarb. dapk-1(gk219) mutants behaved similarly to N2 wild type 
worms in their paralysis sensitivity to aldicarb (though snt-1 worms showed high resistance to 
aldicarb, not shown).   11) At least 30 L4- young adult worms from animals mutant in dapk-1(gk219) 
or nmr-1(ak4);glr-2(ak10),glr-1(ky176)  were compared to N2 wild type animals for changes in 
duration of forwards runs. No statistical significance was observed between dapk-1(gk219) mutants 
and N2 animals, but a large and strongly significant difference was observed when compared to 
animals carrying nmr-1(ak4);glr-2(ak10),glr-1(ky176). 
CKK-1 does not Play a Role in Nematode Excitotoxicity 
    Recent findings using yeast two-hybrid experiments have revealed CaM- regulated protein kinase 
kinase (CaMKK) as a substrate with a high affinity phosphorylation site for DAPk interaction 33. A 
possible inhibition by DAPk is especially significant because CaMKK phosphorylates CaMKI/IV, which 
activates the transcription factor CREB inside the nucleus to confer the activation of neuro-protective 
genes 114. Another student in our lab (K. Genevieve Feldmann) has recently shown that CREB/crh-
1KO confers neuroprotection in nematode excitotoxicity (unpublished data).  We wanted to test 
whether a mutation in ckk-1 (C. elegans ortholog of CaMKK) in Δglt-3;nuIs5 or dapk-1(gk219);Δglt-




and generated ckk-1; Δglt-3;nuIs5, and dapk-1(gk219);ckk-1;Δglt-3;nuIs5 animals and compared their 
level of excitotoxic neurodegeneration with animals carrying Δglt-3; nuIs5 and dapk-1 (gk219); Δglt-3; 
nuIs5 mutations serving as a control. Surprisingly, our results showed no difference in the levels of 
necrotic neurodegeneration in the presence or absence of ckk-1 (Fig.12).  This implies that nematode 
excitotoxicity may not be regulated at the level of CaMKK, and that DAPk does not regulate 
nematode excitotoxicity through CKK-1.  
 
  
Figure 12. ckk-1 does not modulate the level of excitotoxicity. About~40 mutant animals from each 
corresponding strain at each developmental stage (L1- Adult) were observed on the extend of swollen 
degenerating neurons (“vacuolated” cells when using Nomarski/DIC microscopy). Results show that 





Death-Associated Protein Kinase (DAPk) is required for nematode excitotoxicity  
    Current mammalian research provides a relatively satisfying understanding of the initial synaptic 
events during brain ischemia, while offering much less information on the molecular events that lead 
to necrotic death following the over-stimulation of post-synaptic GluRs. Therefore, our focus is to 
elucidate the post synaptic events that regulate the mechanism of excitotoxic neurodegeneration 
using our novel, genetically-accessible model of nematode excitotoxicity. In the current studies we 
found out that inhibition and constitutive activation of DAPk modulates nematode excitotoxicity (Fig 
7). Our data corroborates previous mammalian work, where DAPk is suggested to play a crucial role 
in excitotoxicity. However, we still do not know where DAPk is functioning to modulate 
neurodegeneration, nor do we understand the type of mechanism DAPk uses to regulate necrotic 
neurodegeneration. 
An unexpected view of excitotoxic neurodegeneration 
 
Since DAPk is known to control several signaling pathways, including pathways that promote cell 
death, we focused on the DAPk signaling pathways that could potentially modulate the levels of 
neurodegeneration, specifically neurodegeneration by excitotoxicity.   Our first suspect in the list was 
autophagy. Previous reports from other groups suggest that in another C. elegans model of necrosis, 
where a mec-4(d) mutation is used to induce neurotoxicity, neurodegeneration is strongly reduced by 
blocking autophagy105,106. Unexpectedly, our current data suggest that autophagy is not needed for 
excitotoxicity, although it may moderately accompany neurodegeneration (Fig 8-9). Therefore, the 
mechanism of autophagic cell death is not the main pathway that regulates cell death by 
excitotoxicity. In order to further rule out the involvement of autophagy in excitotoxic 
21 
 
neurodegeneration, we have successfully crossed glt-3;nuIs5 mutants with atg-16.2, a factor required 
for membrane elongation in the autophagy pathway.  We are now in the process of confirming the 
homozygosity of the triple mutant (atg-16.2; glt-3; nuIs5). In addition, we are also taking a 
pharmacological approach, where we use 3-methyladenine (3-MA) to block the class III PI3K/hVps34 
(a positive autophagy modulator at both the initiation and maturation stage of autophagosome). If 
autophagy plays a role in nematode excitotoxicity, we expect to see a significant reduction in 
neurodegeneration comparing our experimental groups (atg-16.2; glt-3; nuIs5 or glt-3; nuIs5 + (3-
MA)) versus control groups (glt-3; nuIs5 or glt-3; nuIs5 , no drug). However, the lack of effect of unc-
51 and the lack of evidence for autophagy as reported by DsRED::LGG-1 already argue strongly in 
against a significant role for autophagy in nematode excitotoxicity. 
    We initially thought that autophagy was a determinant factor for nematode excitotoxicity and that 
DAPk was the kinase responsible for activating the machinery to induce cell death. However, the 
involvement of DAPk in neurodegeneration can be independent of autophagy. Importantly, we started 
to dissect others pathways that are regulated by DAPk and can also change the overall activity of Glu 
signaling, thus changing the level of excitotoxicity.  
Death-Associated Protein Kinase (DAPk) does not participate in early events of 
excitotoxicity 
 
   In the quest for identifying DAPk-interacting partners we eliminated two important early events that 
could be influenced by DAPk and potentially modulate the process of excitotoxicity. By using two 
different behavioral assays, we found out that DAPk does not seem to affect the mechanism of 
synaptic vesicle release by interacting with a critical SNARE complex molecule, Syntaxin- 1A, 
(Fig.10). In addition, DAPk is not associated with the overall activity level of post-synaptic GluRs 
(Fig.11). Therefore, we suggest that the involvement of DAPk in nematode excitotoxicity seems to be 
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mediated by one of the many intracellular events it might control at the postsynaptic-neuron. Ultimate 
clarification of the site of DAPk activity will require the postsynaptic-specific modification of its activity. 
 
CaM Kinase Kinase/ CKK-1 does not participate in nematode excitotoxicity 
 
    Based on our current finding, we wanted to identify DAPk substrates that could collaborate or 
participate in excitotoxic neurodegeneration. CaMKK/CKK-1, a key protein for the activation of 
CREB’s neuroprotective effect, became a suspect because DAPk inhibits its activity28. However, our 
current data implies that the absence of CKK-1 under our model of excitotoxicity does not change the 
level of neurodegeneration (Fig.12). A possible explanation for the lack of CKK-1 effect can be that 
the nematode protein has some functional differences from its mammaliam counterpart. For example, 
in spite of overall high sequence conservation, nematode CKK-1 does not have the C-terminal 
sequence that in mammals is phosphorylated by DAPk. These results suggested that we have to look 
for other avenues that could give us a clue to the signaling pathway DAPk is using to affect 

















Ongoing research/ Future Directions 
 
We are currently testing other molecules that are downstream mediators of DAPk known to influence 
several cell death scenarios, including excitotoxicity. To that end, we have successfully crossed dapk-
1 (gk219); Δglt-3; nuIs5 mutants with the following mutants:  
 
a) ced-4 (encoding one of the critical proteins to regulate the process of apoptosis in worms78,79). 
CED-4 is highly conserved from nematode to mammals. Previous work in neuronal necrosis 
suggested that apoptosis does not seem to contribute much to necrotic neuronal cell death in the 
presence of DAPk115.  However, DAPk could potentially divert some of the dying cells in the 
specific process of excitotoxic cell death from apoptosis to necrosis116, causing dapk-1 KO 
animals to show less necrosis. Therefore, we want to generate ced-4; dapk-1 (gk219); Δglt-3; 
nuIs5 and ced-4; Δglt-3; nuIs5 to see if the process of neurodegeneration is regulated by that cell 
death mechanism.  
 
b) DANGER/mab-21. The role of Ca2+ storage in nematode excitotoxicity100, the function of 
DANGER/mab-21 in regulating the activity of IP3-R54, and the ability of DANGER/mab-21 to inhibit 
DAPk117 (thus conferring neuroprotection) suggest that mab-21 might be a good candidate 
molecule to study in nematode excitotoxicity. Therefore, we are currently crossing mab-21(bx53) 
mutants with our excitotoxicity strain.  
 
c) Other downstream mediators of DAPk that play crucial role in Glu signaling at the post-synaptic 
neurons are also strong candidate mediators of DAPk’s involvement in excitotoxicity. We have 
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prioritized the list of these mediators by focusing on the proteins that previous groups have 
reported exert an effect on post-synaptic neurons. At the top of this list we place:  
1) The MAPK protein mpk-177,118-123 has been shown to be regulated by dapk-1 in C. 
elegans102 .MAPKs are known to control synaptic activity by regulating GluR 
trafficking38,39, an effect seen also in worms124.         
2) the Pin142,45,46 is a propyl isomerase that is known to regulate the strength of 
postsynaptic Glu signaling and elevate GluRs expression. We are using its nematode 
homolog pinn-1125, we have successfully crossed it with our excitotoxicity strain, and are 
currently screening for homozygous triple and tetra mutants. 
Depending on the progress and results from these studies, we might also look at other known DAPk 
substrates/interacting proteins28 or perform a genetic screen to suppress the extended 
neurodegeneration seen in our excitotoxicity strain in the absence of dapk-1 (a similar genetic screen 
in the presence of dapk-1 is currently carried out in the lab by A.O. Edokpolo). We hope that the 




















    Brain ischemia is a major health concern in the United States while the effectiveness of the current 
treatments to ameliorate the neuronal damage is very limited.  Therefore, we hope to discover critical 
cellular and molecular events that lead to excitotoxicity. Recent evidence demonstrates that DAPk 
(master regulatory cell death switch) is critical for excitotoxicity. However, the gaps in our 
understanding of its role still need to be filled. We aim to filll those gaps by understanding the 
signaling pathways through which DAPk mediates its neurodegenerative effect. We are taking a novel 
and powerful approach, where we are relying on the nematode C. elegans model of excitotoxicity due 
to its unique qualities, such as a genetic accessibility, the successful track record of using C. elegans 
to elucidate the conserved molecular basis of a number of cell death pathways, the availability of a 
powerful and informative model of excitotoxicity, and the high conservation of DAPk. We find that 
DAPk is a key regulator of excitotoxicity in the nematode, though probably not through its best studied 
effect, the promotion of autophagic cell death. We are currently using this system to further determine 
the mechanism for DAPk’s involvement in excitotoxicity. Based on the current findings and the ability 
to answer questions relatively quickly with this model, we expect to shed light on the possible 
mechanism of DAPk involvement in excitotoxic neurodegeneration, a contribution that might 
ultimately promote suggestions on new therapeutic strategies to mitigate neuronal damage during 








    The following C.elegans strains were obtained from the C.elegans Genetic Center, from the 
Japanese National Bioresource Project for the Experimental Animal “Nematode C. elegans” , or from 
the original producers: WT: Bristol N2; Nematode excitotoxicity model, Δglt-3; nuIs5: ZB1102 Δglt-
3(bz34) IV; nuIs5 V; Δdapk-1: VC432 Δdapk-1(gk219) I; dapk-1 over-expression: CZ9277:  
frIs7[Pnlp-29::GFP ; Pcol-12:DsRed] (IV) ; juEx1933[Phsp16::DAPK-1 ; Pttx-3::RFP] ; Autophagy modulator 
unc-51: CB369 unc-51(e369) V;  Autophagy label, LGG-1:DsRED:  Ex [Plgg-1:: DsRED:: LGG-1; 
Pmyo-2:: GFP]; Glu-regulated mobility defective control Δnmr-1; Δglr-2 Δglr-1:  VM1268 Δnmr-
1(ak4)II; Δglr-2(ak10) Δglr-1(ky176) III; CaMKK KO Δckk-1: Δckk-1(ok1033)III; PINN-1 KO Δpinn-1:   
Δpinn-1(tm2235)II; mpk-1: SD939 mpk-1(ga111)III.     All the crosses were followed by PCR analysis 
and by monitoring nuIs5 GFP expression on glr-1 expressing- interneurons under imaging UV optics 
scope, except unc-51, which was followed by uncoordinated phenotype and sequencing, LGG-
1::DsRED, which was followed by DsRED expression in cells  and juEx1933, which was followed by 
RFP expression on AIY neurons. We constructed the following crossed: Δdapk-1;Δglt-3; nuIs5: 
VC432 and ZB1102 Δdapk-1(gk219) I; Δglt-3(bz34) IV; nuIs5 V; Δglt-3; nuIs5; Phsp16::DAPK-1: 
ZB1102 and juEx1933 [Phsp16::DAPK-1 ; Pttx-3::RFP];Δglt-3(bz34) IV; nuIs5 V; Δglt-3; nuIs5;unc-51: 
ZB1102 and CB369 Δglt-3(bz34) IV; nuIs5 V ; unc-51(e369) V; LGG-1:DsRED; Δglt-3; nuIs5: Ex 
[Plgg-1:: DsRED:: LGG-1; Pmyo-2:: GFP]; Δglt-3(bz34) IV; nuIs5 V; Δckk-1; Δglt-3; nuIs5: Δckk-








    The level of necrotic neurodegeneration in head neurons of animals carrying the over-expression 
of nuIs5 was monitored using an inverted scope under Nomarski Differential Interference Contrast 
(DIC). Animals with no anesthetics were examining from a fresh chunk of agar of nematode culture 
and flipped upside down over a slide.  Swollen “vacuolated-looking” cells located in the area of the 
nerve ring were counted as head neurons undergoing necrosis (suggested in previous protocol100)  
(we occasionally confirmed these dying neurons as neurons postsynaptic to Glu connections by 
verifying their labeling with the GFP co-expressed in nuIs5 animals under the glr-1 promoter). ~50-
100 animals at each developmental stage (L1-adult) were scored for the extent of degenerating 
neurons. Animals carrying [Phsp16::DAPK-1 ; Pttx-3::RFP];Δglt-3(bz34) IV; nuIs5 V mutation were 
placed in a 350C incubator for  2 hours to induce activation of heat shock promoter, left to rest for 
about 30 minutes and scored regularly for two days for the extent of swollen degenerating neurons 
(protocol coordinated with the Chisholm group (UCSD) who developmed the dapk-1 over-expression 
strain 102). Statistical significance between control groups and experimental groups was analyzed 
using z-test score.   
Fluorescence Microscopy Analysis 
   
    Animals carrying Ex [Plgg-1:: DsRED:: LGG-1; Pmyo-2:: GFP]; Δglt-3(bz34) IV; nuIs5 V and Ex [Plgg-1:: 
DsRED:: LGG-1; Pmyo-2:: GFP]; nuIs5 V were analyzed on the extent of glr-1 expressing command 
interneuron undergoing autophagy as co-labeled with GFP & DsRed.  Animals were mounted on a 
2% agar pad with sodium azide (a compound that paralyzed the worms, worms are not scored here 
for vacuolar appearance) and observed using an inverted high power scope containing Nomarski 
Differential Interference Contrast (DIC) and epifluorescence optics. We quantified the amount of 
DsRED intensity in GFP-labeled (glr-1 expressing) neurons, by taking the neuron with the highest 
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DsRED intensity as 100 % and then relatively score the other neurons with smaller DsRED intensity 
percentage as proportion of the neuron with 100 % DsRED intensity (following the procedure used by 
the Tavernarakis lab, who developed this DsRed::LGG-1 marker). A total average of DsRED intensity 
from all neurons undergoing autophagy from single L3-L4 animals and then from the whole 
population was compared between control and experimental group and then analyzed for statistical 
significance of the difference. We also took an average of the number of neurons undergoing 
autophagy and compared between both populations of worms (control versus experimental).  
Behavioral assays  
Behavioral assays on nematode locomotion and worm paralysis were performed blindly following 
standard methods of behavioral analysis98. For Glu-regulated forward mobility we followed the 
protocol of the Maricq group (U Utah)113. For aldicarb assays we followed the Nonet lab protocol 
(Washington U)126. Briefly, we soaked worm plates with aldicarb to a final concentration of 0.5 mM 
and added food. We placed ~30 freshly growing young adult animal onto these plates. The 
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